Hostname: page-component-76d6cb85b7-s74w7 Total loading time: 0 Render date: 2026-07-26T20:18:16.377Z Has data issue: false hasContentIssue false
  • English
  • Français

Telephone triage of suspected head and neck cancer patients during the coronavirus disease 2019 pandemic using the Head and Neck Cancer Risk Calculator version 2

Part of: JLO Coronavirus Collection

Published online by Cambridge University Press:  02 March 2021

S Banerjee Open the ORCID record for S Banerjee [Opens in a new window] ,
D Voliotidis Open the ORCID record for D Voliotidis [Opens in a new window] ,
L Parvin Open the ORCID record for L Parvin [Opens in a new window]  and
S P K Rama
S Banerjee*
Affiliation:
Department of ENT and Head Neck Surgery, University Hospital Coventry and Warwickshire, Coventry, UK
D Voliotidis
Affiliation:
Department of ENT and Head Neck Surgery, University Hospital Coventry and Warwickshire, Coventry, UK
L Parvin
Affiliation:
Department of ENT and Head Neck Surgery, University Hospital Coventry and Warwickshire, Coventry, UK
S P K Rama
Affiliation:
Department of ENT and Head Neck Surgery, University Hospital Coventry and Warwickshire, Coventry, UK
*
Author for correspondence: Mr Swagatam Banerjee, Department of ENT and Head Neck Surgery, University Hospital Coventry and Warwickshire, Clifford Bridge Road, Coventry CV2 2DX, UK E-mail: swagatam.banerjee1@nhs.net
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

Utilisation of the Head and Neck Cancer Risk Calculator version 2 has been recommended during the coronavirus disease 2019 pandemic for the assessment of head and neck cancer referrals. As limited data were available, this study was conducted to analyse the use of the Head and Neck Cancer Risk Calculator version 2 in clinical practice.

Method

Patients undergoing telephone triage in a two-week wait referral clinic were included. Data were collected and analysed using appropriate methods.

Results

Sixty-four patients in the study were risk-stratified into low-risk (51.6 per cent, 33 of 64), moderate-risk (14.1 per cent, 9 of 64) and high-risk (34.4 per cent, 22 of 64) groups. Of the patients, 53.1 per cent (34 of 64) avoided an urgent hospital visit, and 96.9 per cent (62 of 64) were cancer free, while 3.1 per cent (2 of 64) were found to have a head and neck malignancy. The sensitivity, specificity, negative predictive value and accuracy were 50.00 per cent, 66.13 per cent, 99.92 per cent and 66.11 per cent, respectively.

Conclusion

It is reasonable to use the calculator for triaging purposes, but it must always be accompanied by a meticulous clinical thought process.

Keywords

Covid-19NeoplasmsHead and Neck NeoplasmsTriage

Information

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 135 , Issue 3 , March 2021 , pp. 241 - 245
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Mr S Banerjee takes responsibility for the integrity of the content of the paper

References

Cancer Research UK. Head and neck cancers incidence statistics. In: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/head-and-neck-cancers/incidence [15 October 2020]Google Scholar
Warner, E, Scholfield, DW, Adams, A, Richards, P, Ali, S, Ahmed, J et al. North East London coronavirus disease 2019 protocol for diagnostics in two-week wait head and neck cancer patients. J Laryngol Otol 2020;134:680–3CrossRefGoogle ScholarPubMed
Taylor, R, Omakobia, E, Sood, S, Glore, RJ. The impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study. J Laryngol Otol 2020;134:684–7CrossRefGoogle ScholarPubMed
Banerjee, S, Sarkar, S, Bandyopadhyay, SN. Survey and analysis of knowledge, attitude and practice among otolaryngologists in a state in eastern India in relation to the coronavirus disease 2019 pandemic. J Laryngol Otol 2020;134:696–702CrossRefGoogle Scholar
Cancer Research UK. Coronavirus (COVID-19) and cancer treatment. In: https://www.cancerresearchuk.org/about-cancer/cancer-in-general/coronavirus/cancer-treatment [15 October 2020]Google Scholar
Tikka, T, Kavanagh, K, Lowit, A, Jiafeng, P, Burns, H, Nixon, IJ et al. Head and neck cancer risk calculator (HaNC-RC)—V.2. Adjustments and addition of symptoms and social history factors. Clin Otolaryngol 2020;45:380–8CrossRefGoogle ScholarPubMed
INTEGRATE. ENT UK HN Cancer Telephone Triage: Service Evaluation. In: https://entintegrate.co.uk/entuk2wwtt [15 October 2020]Google Scholar
HaNC-RC v.2 (2019). In: http://www.orlhealth.com/risk-calculator-2.html [17 October 2020]Google Scholar
Jamovi. About. In: https://www.jamovi.org/about.html [17 October 2020]Google Scholar
MedCalc. Diagnostic test evaluation calculator. In: https://www.medcalc.org/calc/diagnostic_test.php [11 January 2021]Google Scholar
Office for National Statistics. United Kingdom population mid-year estimate. In: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/timeseries/ukpop/pop [18 October 2020]Google Scholar
ENT UK. Remote triaging of urgent suspected head and neck cancer referrals during Covid-19 pandemic. In: https://www.entuk.org/sites/default/files/files/ENTUK_2WW_Telephone_Triage_Letter.pdf [18 October 2020]Google Scholar
ENT UK. First interim report from the ENT UK INTEGRATE head and neck cancer telephone triage service evaluation. In: https://www.entuk.org/first-interim-report-ent-uk-integrate-head-and-neck-cancer-telephone-triage-service-evaluation?page=1 [11 January 2021]Google Scholar
Langton, S, Siau, D, Bankhead, C. Two-week rule in head and neck cancer 2000–14: a systematic review. Br J Oral Maxillofac Surg 2016;54:120–31CrossRefGoogle ScholarPubMed
Kumar, R, Drinnan, M, Mehanna, H, Paleri, V. Efficacy of the two-week wait referral system for head and neck cancer: a systematic review. Bull R Coll Surg Engl 2012;94:101–5CrossRefGoogle Scholar
McCarthy, CE, Field, JK, Rajlawat, BP, Field, AE, Marcus, MW. Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011. Int J Oncol 2015;47:204–10CrossRefGoogle ScholarPubMed
ENT UK. Aerosol Generating Procedures (AGPs) within the ENT clinic. In: https://www.entuk.org/sites/default/files/Aerosol Generating Procedures %28AGPs%29 within the ENT clinic.pdf [25 October 2020]Google Scholar
Paleri, V, Hardman, J, Tikka, T, Bradley, P, Pracy, P, Kerawala, C. Rapid implementation of an evidence-based remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: model for international collaboration. Head Neck 2020;42:1674–80CrossRefGoogle ScholarPubMed
NHS England. Cancer alliance information on managing cancer referrals. In: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/cancer-alliance-information-on-managing-cancer-referrals-19-march-2020.pdf [26 October 2020]Google Scholar